HS-10380 High Dose: Clinical Trials

1 trial of HS-10380 High Dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow HS-10380 High Dose: new trials by email Literature Review of HS-10380 High Dose trials Research Report on HS-10380 High Dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
HS-10380 Low Dose, HS-10380 Medium dose, HS-10380 High Dose - SCHIZOPHRENIA 1 (Disorder)
Phase 2CompletedJiangsu Hansoh Pharmaceutical Co., Ltd.3632024-05-232026-04-24

Conditions studied

Schizophrenia (1)

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd. (1)

Countries

China (1)